Comparison of transcatheter arterial chemoembolization and microsphere embolization for treatment of unresectable hepatocellular carcinoma: A meta-analysis

Journal of Cancer Research and Clinical Oncology

Volumn 138, Issue 3, 2012, Pages 455-462

  Xie, Feng ^a   Zang, Jiajie ^a   Guo, Xiaojing ^a   Xu, Feng ^a   Shen, Rongxi ^a   Yan, Long ^a   Yang, Jiamei ^a   He, Jia ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Chemotherapy; HCC; Microsphere embolization; Survival; Transarterial chemoembolization; Treatment response

Indexed keywords

EPIRUBICIN; METHOTREXATE; MITOMYCIN C; PHOSPHORUS 32; YTTRIUM 90; MICROSPHERE;

ARTICLE; ARTIFICIAL EMBOLISM; CANCER GROWTH; CANCER SURVIVAL; CHEMOEMBOLIZATION; HUMAN; INOPERABLE CANCER; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; META ANALYSIS; MICROSPHERE EMBOLIZATION; OVERALL SURVIVAL; PRIORITY JOURNAL; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; ADULT; AGED; CANCER STAGING; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; FEMALE; HEPATIC ARTERY; LIVER TUMOR; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; DISEASE-FREE SURVIVAL; EMBOLIZATION, THERAPEUTIC; FEMALE; HEPATIC ARTERY; HUMANS; LIVER NEOPLASMS; MALE; MICROSPHERES; MIDDLE AGED; NEOPLASM STAGING; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84859717076     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-011-1117-7     Document Type: Article

References (39)

1. Ahmad J, Rhee J, Carr BI (2005) The effects of hepatic artery chemotherapy on viral hepatitis in patients with hepatocellular carcinoma. Dig Dis Sci 50:331-335 (Pubitemid 40311543)
2. Bartolozzi C, Lencioni R, Caramella D, Vignali C, Cioni R, Mazzeo S et al (1995) Treatment of large HCC: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization. Radiology 197:812-818
3. Bruix J, Sherman M, Practice Guidelines Committee, American Association for the Study of Liver Diseases (2005) Management of hepatocellular carcinoma. Hepatology 42:1208-1236 (Pubitemid 43112690)
4. Burton MA, Gray BN, Klemp PF, Kelleher DK, Hardy N (1989) Selective internal radiation therapy: distribution of radiation in the liver. Eur J Cancer Clin Oncol 25:1487-1491 (Pubitemid 19247458)
5. Cao GW, Hu S, Li G et al (2005a) The clinical and experimental research of transhepatic arterial injection of 32P-glass microsphere therapy for hepatic carcinoma. J Med Imaging 15(8):678-681
6. Cao XC, Wang X, Tan J, Li B, Wang R, Liu Y, Chang Y, Zhang L, Wang J, Yan S (2005b) Clinical research of intra-arterial radioembolization with 32P-gass microspheres combined with chemoembolization for treatment of liver cancer. Chin J Radiol 39(10):1068-1072
7. Carr BI (2004) Hepatic arterial 90 yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients. Liver Transplant 10:S107-S110 (Pubitemid 38240109)
8. Carr BI, Kondragunta V, Buch SC, Branch RA (2010) Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma. Cancer 116:1305-1314
9. Cheng AL, Kang YK, Chen Z et al (2009) Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol 10:25-34
10. Du W, Lin S, Luo K et al (2002) Clinical analysis of TACE plus 32PGMS in advanced hepatic carcinoma. J Hepatobilia Surg 10(5):351-352
11. Goin JE, Dancey JE, Roberts CA, Sickles CJ, Leung DA, Soulen MC (2004) Comparison of post-embolization syndrome in the treatment of patients with unresectable hepatocellular carcinoma: transcatheter arterial chemo-embolization versus yttrium- 90 glass microspheres. World J Nuc Med 3:49-56
12. Gray B, Van Hazel G, Hope M et al (2001) Randomised trial of SIRSpheres plus chemotherapy versus chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol 12:1711-1720 (Pubitemid 34105661)
13. Hao N, Xiao X, Han X et al (2000) Efficacy of intra-arterial chemoembolization using drug microspheres in compare with chemoembolization in the treatment of primary hepatic carcinoma. Tumor (Shanghai) 20(5):375-378
14. Heckman JT, Devera MB, Marsh JW et al (2008) Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation. Ann Surg Oncol 15:3169-3177
15. Hou P, Guan G, Zhang X, Lu H, Wang S (2006) Effects of intraadvanced 32P glass microspheres for advanced hepatic carcinoma. Academic journal of Fujian medical university 40(1):48-50
16. Ibrahim SM, Lewandowski RJ, Ryu RK et al (2008) Radiographic response to yttrium-90 radioembolization in anterior versus posterior liver segments. Cardiovasc Intervent Radiol 31:1124-1132
17. Kirchhoff TD, Rudolph KL, Layer G, Chavan A, Greten TF, Rosenthal H, Kubicka S, Galanski M, Manns MP, Schild H, Gallkowski U (2006) Chemoocclusion vs. chemoperfusion for treatment of advanced hepatocellular carcinoma: a randomised trial. Eur J Surg Oncol 32(2):201-207 (Pubitemid 43257124)
18. Kooby DA, Egnatashvili V, Srinivasan S, Chamsuddin A, Delman KA, Kauh J, Staley CA III, Kim HS (2009) Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma. J Vasc Interv Radiol 21(2):224-230
19. Kulik LM, Atassi B, van Holsbeeck L, Souman T, Lewandowski RJ, Mulcahy MF, Hunter RD, Nemcek AA Jr, Abecassis MM, Haines KG III, Salem R (2006) Yttrium-90 microspheres (Thera Sphere) treatment of unresectable hepatocellular carcinoma: down staging to resection, RFA and bridge to transplantation. J Surg Oncol 94:572-586 (Pubitemid 44851918)
20. Kulik LM, Carr BI, Mulcahy MF et al (2008) Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis. Hepatology 47:71-81 (Pubitemid 351171043)
21. Lau WY, Ho S, Leung TW et al (1998) Selective internal radiation therapy for non resectable hepatocellular carcinoma with intraarterial infusion of 90 yttrium microspheres. Int J Radiat Oncol Biol Phys 40:583-592 (Pubitemid 28104228)
22. Lee W, Luo J, Yan Z et al (2008) Hepatic radioembolization with epirubicin mixed microsphere for the treatment of hepatocellular carcinoma. J Nantong Univ (Medical Sciences) 28(4):268-270
23. Leelawat K, Laisupasin P, Kiatdilokrut A et al (2008) The effect of doxorubicin on the changes of serum vascular endothelial growth factor (VEGF) in patients with hepatocellular carcinoma after transcatheter arterial chemoembolization (TACE). J Med Assoc Thai 91:1539-1543
24. Lencioni R, Cioni D, Crocetti L et al (2005) Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 234:961-967 (Pubitemid 40250844)
25. Lewandowski RJ, Kulik LM, Riaz A, Senthilnathan S, Mulcahy MF, Ryu RK, Ibrahim SM, Sato KT, Baker T, Miller FH, Omary R, Abecassis M, Salem R (2009) A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization. Am J Transplant 9(8):1920-1928
26. Lewandowski RJ, Mulcahy MF, Kulik LM et al (2010) Chemoembolization for hepatocellular carcinoma: comprehensive imaging and survival analysis in a 172-patient cohort. Radiology 255:955-965
27. Liu T, Zu M (2005) Treatment of primary hepatic carcinoma by hepatic arterial chemoembolization with KMG microspheres and chemotherapeutic agents. Acad Med Xuzhou 25(2):126-129
28. Llovet JM, Bruix J (2003) Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 37:429-442 (Pubitemid 36152543)
29. Llovet JM, Real MI, Montana X et al (2002) Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359:1734-1739 (Pubitemid 34607087)
30. Lo CM, Ngan H, Tso WK et al (2002) Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35:1164-1171 (Pubitemid 34454013)
31. Mathurin P, Rixe O, Carbonell N, Bernard B, Cluzel P, Bellin MF et al (1998) Review article: overview of medical treatments in unresectable hepatocellular carcinoma-an impossible meta-analysis? Aliment Pharmacol Ther 12:111-126 (Pubitemid 28059978)
32. Mazzaferro V, Regalia E, Doci R et al (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334:693-699 (Pubitemid 26079803)
33. Parkin DM, Bray F, Ferlay J, Pisani P (2001) Estimating the world cancer burden: globocan 2000. Int J Cancer 94:153-156 (Pubitemid 32911406)
34. Parmar MK, Torri V, Stewart L (1998) Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 17:2815-2834 (Pubitemid 28562978)
35. Poon RT, Ngan H, Lo CM, Liu CL, Fan ST, Wong J (2000) Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence. J Surg Oncol 73:109-114 (Pubitemid 30123735)
36. Salem R, Lewandowski RJ, Kulik L, Wang E, Riaz A, Ryu RK, Sato KT, Gupta R, Nikolaidis P, Miller FH, Yaghmai V, Ibrahim SM, Senthilnathan S, Baker T, Gates VL, Atassi B, Newman S, Memon K, Chen R, Vogelzang RL, Nemcek AA, Resnick SA, Chrisman HB, Carr J, Omary RA, Abecassis M, Benson AB 3rd, Mulcahy MF (2011) Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma. Gastroenterology 140(2):497-507
37. Sato K, Lewandowski RJ, Bui JT et al (2006) Treatment of unresectable primary and metastatic liver cancer with Yttrium- 90 microspheres (Thera Sphere): assessment of hepatic arterial embolization. Cardiovasc Intervent Radiol 29:522-529 (Pubitemid 43822993)
38. Simonetti RG, Liberati A, Angiolini C, Pagliaro L (1997) Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials. Ann Oncol 8:117-136 (Pubitemid 27112878)
39. Virmani S, Rhee TK, Ryu RK et al (2008) Comparison of hypoxiainducible factor-1a expression before and after transcatheter arterial embolization in rabbit VX2 liver tumors. J Vasc Interv Radiol 19:1483-1489